1887

Journal of Medical Microbiology logo

Volume 64, Issue 7

An update on human immunodeficiency virus vaccine preparedness studies Free

Abstract

Human immunodeficiency virus (HIV) vaccine preparedness studies (VPSs) have taken place in both the Organisation for Economic Co-operation and Development (OECD) countries and the non-OECD countries. HIV VPSs are conducted to assess the feasibility of phase 3 HIV vaccine trials. This descriptive review is an update of HIV VPSs in the non-OECD countries, and examines the willingness to participate (WTP) in hypothetical HIV vaccine trials, as well as retention. Few VPSs have been published in the OECD countries since the discontinuation of the STEP/Phambili HIV vaccine trials. Barriers to participation in the non-OECD countries after the STEP/Phambili studies include safety issues and side effects, vaccine-induced seropositivity (VISP) and mistrust among key informants (KIs). HIV VPSs indicate that HIV vaccine trials are still feasible in the non-OECD countries, but barriers must be overcome to improve feasibility. Hypothetical WTP in a VPS may not translate into actual WTP in an HIV vaccine trial.

  • Received:
  • Accepted:
  • Published Online:
© 2015 The Authors
Loading

Article metrics loading...

/content/journal/jmm/10.1099/jmm.0.000073
2015-07-01
2024-04-24
Loading full text...

Full text loading...

/deliver/fulltext/jmm/64/7/731.html?itemId=/content/journal/jmm/10.1099/jmm.0.000073&mimeType=html&fmt=ahah

References

  1. Adler D.H. 2012; Inclusion of South African adolescents in HIV vaccine trials. J AIDS HIV Res 4:30–35[PubMed]
     [Google Scholar]
  2. Asiki G., Abaasa A., Ruzagira E., Kibengo F., Bahemuka U., Mulondo J., Seeley J., Bekker L.G., Delany S., other authors. 2013; Willingness to participate in HIV vaccine efficacy trials among high risk men and women from fishing communities along Lake Victoria in Uganda. Vaccine 31:5055–5061 [View Article][PubMed]
     [Google Scholar]
  3. Buchbinder S.P., Metch B., Holte S.E., Scheer S., Coletti A., Vittinghoff E. 2004; Determinants of enrollment in a preventive HIV vaccine trial: hypothetical versus actual willingness and barriers to participation. J Acquir Immune Defic Syndr 36:604–612 [View Article][PubMed]
     [Google Scholar]
  4. Buchbinder S.P., Mehrotra D.V., Duerr A., Fitzgerald D.W., Mogg R., Li D., Gilbert P.B., Lama J.R., Marmor M., other authors. 2008; Efficacy assessment of a cell-mediated immunity HIV-1 vaccine (the Step Study): a double-blind, randomised, placebo-controlled, test-of-concept trial. Lancet 372:1881–1893 [View Article][PubMed]
     [Google Scholar]
  5. Chakrapani V., Newman P.A., Singhal N., Jerajani J., Shunmugam M. 2012; Willingness to participate in HIV vaccine trials among men who have sex with men in Chennai and Mumbai, India: a social ecological approach. PLoS One 7:e51080 [View Article][PubMed]
     [Google Scholar]
  6. Chariyalertsak S., Kosachunhanan N., Saokhieo P., Songsupa R., Wongthanee A., Chariyalertsak C., Visarutratana S., Beyrer C. 2011; HIV incidence, risk factors, and motivation for biomedical intervention among gay, bisexual men, and transgender persons in Northern Thailand. PLoS One 6:e24295 [View Article][PubMed]
     [Google Scholar]
  7. Chu Z., Xu J., Reilly K.H., Lu C., Hu Q., Ma N., Zhang M., Zhang J., Jiang Y., other authors. 2013; HIV related high risk behaviors and willingness to participate in HIV vaccine trials among China MSM by computer assisted self-interviewing survey. BioMed Res Int 2013:493128 [View Article][PubMed]
     [Google Scholar]
  8. de Bruyn G., Skhosana N., Robertson G., McIntyre J.A., Gray G.E. 2008; Knowledge and attitudes towards HIV vaccines among Soweto adolescents. BMC Res Notes 1:76 [View Article][PubMed]
     [Google Scholar]
  9. Deschamps M.M., Zorrilla C.D., Morgan C.A., Donastorg Y., Metch B., Madenwald T., Joseph P., Severe K., Garced S., other authors. 2013; Recruitment of Caribbean female commercial sex workers at high risk of HIV infection. Rev Panam Salud Publica 34:92–98[PubMed]
     [Google Scholar]
  10. Dhalla S., Poole G. 2011; Barriers of enrolment in HIV vaccine trials: a review of HIV vaccine preparedness studies. Vaccine 29:5850–5859 [View Article][PubMed]
     [Google Scholar]
  11. Dhalla S., Woods R., Strathdee S.A., Patrick D.M., Hogg R.S. 2007; HIV vaccine preparedness studies in the organization for economic co-operation and development (OECD) countries. AIDS Care 19:1118–1127 [View Article][PubMed]
     [Google Scholar]
  12. Dhalla S., Nelson K.E., Singer J., Poole G. 2009; HIV vaccine preparedness studies in the non-organization for economic co-operation and development (non-OECD) countries. AIDS Care 21:335–348 [View Article][PubMed]
     [Google Scholar]
  13. Etcheverry M.F., Evans J.L., Sanchez E., Mendez-Arancibia E., Meroño M., Gatell J.M., Page K., Joseph J. 2013; Enhanced retention strategies and willingness to participate among hard-to-reach female sex workers in Barcelona for HIV prevention and vaccine trials. Hum Vaccin Immunother 9:420–429 [View Article][PubMed]
     [Google Scholar]
  14. Francis D.P., Heyward W.L., Popovic V., Orozco-Cronin P., Orelind K., Gee C., Hirsch A., Ippolito T., Luck A., other authors. 2003; Candidate HIV/AIDS vaccines: lessons learned from the World's first phase III efficacy trials. AIDS 17:147–156 [View Article][PubMed]
     [Google Scholar]
  15. Geis S., Maboko L., Saathoff E., Hoffmann O., Geldmacher C., Mmbando D., Samky E., Michael N.L., Birx D.L., other authors. 2011; Risk factors for HIV-1 infection in a longitudinal, prospective cohort of adults from the Mbeya Region, Tanzania. J Acquir Immune Defic Syndr 56:453–459 [View Article][PubMed]
     [Google Scholar]
  16. Giocos G., Kagee A., Swartz L. 2008; Predicting hypothetical willingness to participate (WTP) in a future phase III HIV vaccine trial among high-risk adolescents. AIDS Behav 12:842–851 [View Article][PubMed]
     [Google Scholar]
  17. Gray G.E., Moodie Z., Metch B., Gilbert P.B., Bekker L.G., Churchyard G., Nchabeleng M., Mlisana K., Laher F., other authors. 2014; Recombinant adenovirus type 5 HIV gag/pol/nef vaccine in South Africa: unblinded, long-term follow-up of the phase 2b HVTN 503/Phambili study. Lancet Infect Dis 14:388–396 [View Article][PubMed]
     [Google Scholar]
  18. Hammer S.M., Sobieszczyk M.E., Janes H., Karuna S.T., Mulligan M.J., Grove D., Koblin B.A., Buchbinder S.P., Keefer M.C., other authors. 2013; Efficacy trial of a DNA/rAd5 HIV-1 preventive vaccine. N Engl J Med 369:2083–2092 [View Article][PubMed]
     [Google Scholar]
  19. Jaspan H.B., Berwick J.R., Myer L., Mathews C., Flisher A.J., Wood R., Bekker L.G. 2006; Adolescent HIV prevalence, sexual risk, and willingness to participate in HIV vaccine trials. J Adolesc Health 39:642–648 [View Article][PubMed]
     [Google Scholar]
  20. Kiwanuka N., Ssetaala A., Mpendo J., Wambuzi M., Nanvubya A., Sigirenda S., Nalutaaya A., Kato P., Nielsen L., other authors. 2013; High HIV-1 prevalence, risk behaviours, and willingness to participate in HIV vaccine trials in fishing communities on Lake Victoria, Uganda. J Int AIDS Soc 16:18621 [View Article][PubMed]
     [Google Scholar]
  21. Lindegger G., Quayle M., Ndlovu M. 2007; Local knowledge and experiences of vaccination: implications for HIV-preventive vaccine trials in South Africa. Health Educ Behav 34:108–123 [View Article][PubMed]
     [Google Scholar]
  22. Ma M., Toni Young A., Durham M., Kibler J.L., Gaul Z., Pals S., Sutton M.Y. 2014; Predictors of willingness of participate in HIV vaccine trials among African Americans. J AIDS Clin Res 5:361
     [Google Scholar]
  23. Middelkoop K., Myer L., Mark D., Mthimunye S.P., Smit J., Wood R., Bekker L.G. 2008; Adolescent and adult participation in an HIV vaccine trial preparedness cohort in South Africa. J Adolesc Health 43:8–14 [View Article][PubMed]
     [Google Scholar]
  24. Newman P.A., Chakrapani V., Weaver J., Shunmugam M., Rubincam C. 2014; Willingness to participate in HIV vaccine trials among men who have sex with men in Chennai and Mumbai, India. Vaccine 32:5854–5861 [View Article][PubMed]
     [Google Scholar]
  25. NIH US National Library of Medicine 2007; Clinical alert: immunizations are discontinued in two HIV vaccine trials. http://www.nlm.nih.gov/databases/alerts/hiv_step_study.html Accessed July 3, 2015
  26. OECD 2011 Better Policies for Better Lives http://www.oecd.org/general/oecdat50betterpoliciesforbetterlives.html. Accessed July 4, 2015
    [Google Scholar]
  27. Olanrewaju O., Onigbogi M., Omobola O. 2014; Willingness to participate (WTP) in HIV vaccine trials among itinerant female hairdressers in Ibadan, Nigeria. J AIDS Clin Res 5:325 [View Article]
     [Google Scholar]
  28. Otwombe K.N., Sikkema K.J., Dietrich J., de Bruyn G., van der Watt M., Gray G.E. 2011; Willingness to participate in biomedical HIV prevention studies after the HVTN 503/Phambili trial: a survey conducted among adolescents in Soweto, South Africa. J Acquir Immune Defic Syndr 58:211–218 [View Article][PubMed]
     [Google Scholar]
  29. Pitisuttithum P., Gilbert P., Gurwith M., Heyward W., Martin M., van Griensven F., Hu D., Tappero J.W., Choopanya K. 2006; Bangkok Vaccine Evaluation Group Randomized, double-blind, placebo-controlled efficacy trial of a bivalent recombinant glycoprotein 120 HIV-1 vaccine among injection drug users in Bangkok, Thailand. J Infect Dis 194:1661–1671 [View Article][PubMed]
     [Google Scholar]
  30. Price M.A., Rida W., Mwangome M., Mutua G., Middelkoop K., Roux S., Okuku H.S., Bekker L.G., Anzala O., other authors. 2012; Identifying at-risk populations in Kenya and South Africa: HIV incidence in cohorts of men who report sex with men, sex workers, and youth. J Acquir Immune Defic Syndr 59:185–193 [View Article][PubMed]
     [Google Scholar]
  31. Rerks-Ngarm S., Pitisuttithum P., Nitayaphan S., Kaewkungwal J., Chiu J., Paris R., Premsri N., Namwat C., de Souza M., other authors. 2009; Vaccination with ALVAC and AIDSVAX to prevent HIV-1 infection in Thailand. N Engl J Med 361:2209–2220 [View Article][PubMed]
     [Google Scholar]
  32. Rida W., Fast P., Hoff R., Fleming T. 1997; Intermediate-size trials for the evaluation of HIV vaccine candidates: a workshop summary. J Acquir Immune Defic Syndr Hum Retrovirol 16:195–203 [View Article][PubMed]
     [Google Scholar]
  33. Ruzagira E., Wandiembe S., Bufumbo L., Levin J., Price M.A., Grosskurth H., Kamali A. 2009; Willingness to participate in preventive HIV vaccine trials in a community-based cohort in south western Uganda. Trop Med Int Health 14:196–203 [View Article][PubMed]
     [Google Scholar]
  34. Ruzagira E., Wandiembe S., Abaasa A., Bwanika A.N., Bahemuka U., Amornkul P., Price M.A., Grosskurth H., Kamali A. 2011; HIV incidence and risk factors for acquisition in HIV discordant couples in Masaka, Uganda: an HIV vaccine preparedness study. PLoS One 6:e24037 [View Article][PubMed]
     [Google Scholar]
  35. Scheer S., Douglas J.M. Jr, Vittinghoff E., Bartholow B.N., McKirnan D., Judson F.N., MacQueen K.M., Buchbinder S. 1999; Feasibility and suitability of targeting young gay men for HIV vaccine efficacy trials. J Acquir Immune Defic Syndr Hum Retrovirol 20:172–178 [View Article][PubMed]
     [Google Scholar]
  36. Seage G.R. III, Holte S.E., Metzger D., Koblin B.A., Gross M., Celum C., Marmor M., Woody G., Mayer K.H., other authors. 2001; Are US populations appropriate for trials of human immunodeficiency virus vaccine? The HIVNET Vaccine Preparedness Study. Am J Epidemiol 153:619–627 [View Article][PubMed]
     [Google Scholar]
  37. Smit J., Middelkoop K., Myer L., Seedat S., Bekker L-G., Stein D.J. 2006; Willingness to participate in HIV vaccine research in a peri-urban South African community. Int J STD AIDS 17:176–179 [CrossRef]
     [Google Scholar]
  38. Suhadev M., Nyamathi A.M., Swaminathan S., Suresh A., Venkatesan P. 2009; Factors associated with willingness to participate in HIV vaccine trials among high-risk populations in South India. AIDS Res Hum Retroviruses 25:217–224 [View Article][PubMed]
     [Google Scholar]
  39. UNAIDS 2013; Global report. UNAIDS report on the global AIDS epidemic 2013. http://www.unaids.org/en/media/unaids/contentassets/documents/epidemiology/2013/gr2013/UNAIDS_Global_Report_2013_en.pdf. Accessed July 3, 2015.
http://instance.metastore.ingenta.com/content/journal/jmm/10.1099/jmm.0.000073
Loading
An update on human immunodeficiency virus vaccine preparedness studies
J. Med. Microbiol. 64, 731 (2015); https://doi.org/10.1099/jmm.0.000073
/content/journal/jmm/10.1099/jmm.0.000073
/content/journal/jmm/10.1099/jmm.0.000073
Loading

Data & Media loading...

Supplements

Supplementary Data

PDF

Most cited Most Cited RSS feed

This is a required field
Please enter a valid email address
Approval was a Success
Invalid data
An Error Occurred
Approval was partially successful, following selected items could not be processed due to error